Optimal Management of Peripheral Arterial Disease for the Non-specialist

Overview

Journal Ulster Med J

Specialty General Medicine

Date 2012 Feb 21

PMID 22347739

Citations 9

Authors

M E ODonnell

J A Reid

L L Lau

R J Hannon

B Lee

Affiliations

Soon will be listed here.

Abstract

Peripheral arterial disease (PAD) now affects approximately 20% of adults older than 55 years to an estimated total of 27 million people in the Western World. The aim of this paper is to describe the medical management of PAD for the non-vascular specialist, particularly general practitioners, where PAD has now been included in the Northern Ireland Department of Health's Primary Care Service Framework (Directed Enhanced Service).

Citing Articles

An audit of secondary prevention for peripheral arterial disease in primary care - scope for improved collaboration between vascular surgery and general practitioners.

Foley M, Tubassam M, Walsh S Ir J Med Sci. 2023; 192(6):3007-3010.

PMID: 37099256 PMC: 10692140. DOI: 10.1007/s11845-023-03362-1.

Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): results from a randomised controlled feasibility trial.

Bosanquet D, Ambler G, Waldron C, Thomas-Jones E, Brookes-Howell L, Kelson M BMJ Open. 2019; 9(11):e029233.

PMID: 31719071 PMC: 6858124. DOI: 10.1136/bmjopen-2019-029233.

Living a burdensome and demanding life: A qualitative systematic review of the patients experiences of peripheral arterial disease.

Abaraogu U, Ezenwankwo E, Dall P, Seenan C PLoS One. 2018; 13(11):e0207456.

PMID: 30440040 PMC: 6237376. DOI: 10.1371/journal.pone.0207456.

Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program.

Abaraogu U, Ezenwankwo E, Dall P, Tew G, Stuart W, Brittenden J PLoS One. 2018; 13(7):e0201095.

PMID: 30048501 PMC: 6062088. DOI: 10.1371/journal.pone.0201095.

Perineural local anaesthetic catheter after major lower limb amputation trial (PLACEMENT): study protocol for a randomised controlled pilot study.

Bosanquet D, Ambler G, Waldron C, Thomas-Jones E, Brookes-Howell L, Kelson M Trials. 2017; 18(1):629.

PMID: 29284534 PMC: 5747086. DOI: 10.1186/s13063-017-2357-x.

References

Hooi J, Kester A, Stoffers H, Overdijk M, Van Ree J, Knottnerus J . Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol. 2001; 153(7):666-72. DOI: 10.1093/aje/153.7.666. View

Ota H, Takase K, Igarashi K, Chiba Y, Haga K, Saito H . MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol. 2003; 182(1):201-9. DOI: 10.2214/ajr.182.1.1820201. View

ODonnell M, Badger S, Sharif M, Young I, Lee B, Soong C . The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg. 2009; 49(5):1226-34. DOI: 10.1016/j.jvs.2008.11.098. View

Lonn E, Yusuf S, Arnold M, Sheridan P, Pogue J, Micks M . Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006; 354(15):1567-77. DOI: 10.1056/NEJMoa060900. View

VAN NUETEN J, Janssen P . Effect of cinnarizine on peripheral circulation in dogs. Eur J Pharmacol. 1972; 17(1):103-6. DOI: 10.1016/0014-2999(72)90275-0. View

Caputo G, Cavanagh P, Ulbrecht J, Gibbons G, Karchmer A . Assessment and management of foot disease in patients with diabetes. N Engl J Med. 1994; 331(13):854-60. DOI: 10.1056/NEJM199409293311307. View

Fowkes G, Gillespie I . WITHDRAWN: Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev. 2018; 3:CD000017. PMC: 6494181. DOI: 10.1002/14651858.CD000017.pub2. View

. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360(9326):7-22. DOI: 10.1016/S0140-6736(02)09327-3. View

Badger S, Soong C, ODonnell M, Boreham C, McGuigan K . Benefits of a supervised exercise program after lower limb bypass surgery. Vasc Endovascular Surg. 2007; 41(1):27-32. DOI: 10.1177/1538574406296209. View

10.

Chapman T, Goa K . Cilostazol: a review of its use in intermittent claudication. Am J Cardiovasc Drugs. 2004; 3(2):117-38. DOI: 10.2165/00129784-200303020-00006. View

11.

Reid J, Wolsley C, Lau L, Hannon R, Lee B, Young I . The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol. Eur J Vasc Endovasc Surg. 2005; 30(5):464-8. DOI: 10.1016/j.ejvs.2005.05.007. View

12.

Lederman R, Mendelsohn F, Anderson R, Saucedo J, Tenaglia A, Hermiller J . Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 2002; 359(9323):2053-8. DOI: 10.1016/s0140-6736(02)08937-7. View

13.

Robless P, Mikhailidis D, Stansby G . Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008; (1):CD003748. DOI: 10.1002/14651858.CD003748.pub3. View

14.

Koelemay M, Legemate D, Reekers J, Koedam N, Balm R, Jacobs M . Interobserver variation in interpretation of arteriography and management of severe lower leg arterial disease. Eur J Vasc Endovasc Surg. 2001; 21(5):417-22. DOI: 10.1053/ejvs.2001.1328. View

15.

Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F . Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2006; 33 Suppl 1:S1-75. DOI: 10.1016/j.ejvs.2006.09.024. View

16.

Hooi J, Kester A, Stoffers H, Rinkens P, Knottnerus J, Van Ree J . Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol. 2004; 57(3):294-300. DOI: 10.1016/j.jclinepi.2003.09.003. View

17.

Stead L, Bergson G, Lancaster T . Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008; (2):CD000165. DOI: 10.1002/14651858.CD000165.pub3. View

18.

Balsano F, Coccheri S, LIBRETTI A, Nenci G, Catalano M, Fortunato G . Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial. J Lab Clin Med. 1989; 114(1):84-91. View

19.

ODonnell M, Badger S, Sharif M, Makar R, Young I, Lee B . The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease. Vasc Endovascular Surg. 2009; 43(2):132-43. DOI: 10.1177/1538574408328586. View

20.

Selvin E, Erlinger T . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110(6):738-43. DOI: 10.1161/01.CIR.0000137913.26087.F0. View